Nephrolithiasis is the second most common kidney disease and a known risk factor of chronic kidney disease. How ever, the pathophysiology of nephro lithiasis remains poorly understood, and there have been few, if any, advances in the treatment of kidney stones in years. Th us, the development of new animal models of stone disease may allow for a better understanding of the pathophysiology underlying urolithiasis and open opportunities for new therapeutic approaches.
The prevalence of kidney stones has been increasing in parallel with other epidemics, such as obesity, diabetes mellitus, hypertension, and the metabolic syndrome, associated with the development of Western cultures. 1 Calcium oxalate (CaOx) is the predominant type of kidney stone disease, occurring in the majority of the kidney stone population in the United States. 2 It is estimated that kidney stones account for more than $ 5 billion per year in economic costs in the United States for hospitalizations, stone removal, and time lost from work. 3 Despite the high prevalence and cost of nephrolithiasis and the frequent recurrence aft er the fi rst stone, our understanding of how genetic, environmental, and metabolic factors act singly or in concert to trigger stone formation remains patchy, and the progress of medical therapy has been very modest. In idiopathic hyperoxaluria, which is present in 40 % of stone formers, no proven pharmacotherapy has been established. 4 Th erefore, basic research directed at model systems that elucidate the pathophysiology of CaOx stone disease in combination with clinical research is the best hope for advancing the field and leading to the development of new therapeutic approaches that have the potential to reduce the morbidity, mortality, and cost associated with this disease.
Chen and colleagues 5 (this issue) now present a new model of CaOx nephrolithiasis in the fruitfl y Drosophila melanogaster . In Drosophila , the Malphigian tubules are considered the fl y kidney and represent the excretory and osmoregulatory system. However, unlike the vertebrate kidney, the Drosophila kidney does not have a glomerular-like structure, so the luminal fl uid is not generated by a fi ltration process. 6 Figure 1 is a schematic diagram of the Malphigian tubule system showing the absence of a glomerular-like structure, but the secretion of salts, water, and waste products into blunt-end tubular structures and the emptying of the tubular contents into the gastrointestinal system, where reabsorptive processes represent the fi nal regulation of water and nutrient excretion. As indicated in Figure 1 , Chen et al. 5 fed fruitfl ies three lithogenic agents: ethylene glycol (EG), hydroxyl-l -proline (HLP), and sodium oxalate (NaOx). Polarized light microscopic analysis of dissected tubules demonstrated that EG, HLP, and NaOx feeding resulted in crystal formation within the lumen of the tubule in a dose-dependent manner. By energydispersive X-ray spectroscopy and scanning electron microscopy, these crystals were identifi ed as CaOx stones. In a subsequent series of experiments, the investigators demonstrated that EG-induced crystal formation reduced lifespan in Drosophila and that the addition of the litholytic agent potassium citrate (KCit) reduced the EG-induced stone formation and re-extended the fl ies ' lifespan. On the basis of these data, the authors present Drosophila as a new model for experimental induction and treatment of CaOx nephrolithiasis.
Th e addition of an insect model for elucidating the pathophysiology underlying stone disease and potentially developing new therapeutic approaches expands the repertoire of model systems, which have been primarily mouse and rat systems. 7 Th ere are advantages of the Drosophila system that should be noted, namely, (1) the low cost of maintaining Drosophila colonies, (2) the rapid deployment of new transgenic lines, and (3) the ability to test hypotheses in lower-species in vivo systems before embarking on studies in more cumbersome higher-order animals. 6 However, the limitations should also be noted. Th e key limitation is that the insect system is aglomerular, and thus the composition of the fi nal tubular fl uid is based entirely on active secretion rather than ultrafi ltration followed by a combination of reabsorption and secretion. 8 Th e absence of a fi ltration structure is explained by the physical relationship between the blood supply and the tubules: the tubules freely fl oat in the Drosophila : a fruitful model for calcium oxalate nephrolithiasis ?
Felix Knauf 1 and Patricia A. Preisig 1 , 2 Even though the prevalence of nephrolithiasis is increasing, our understanding of the pathophysiology has not kept pace and new therapeutic approaches have not emerged. The potential of a new physiological model (the fruitfly) is exciting. The model has strengths, namely the low cost of maintaining colonies and rapid deployment of new transgenic lines, but also weaknesses that may ultimately limit its usefulness, such as the mechanism of tubular fluid formation and difficulties in following plasma and urine biochemistries.
hemocoel (blood-filled body cavity) rather than having a vascular system that hugs the tubules, as in the mammalian renal system.
The difference in the way filtrate is formed in insect tubules may be a key limitation to understanding the mechanism(s) involved in CaOx nephrolithiasis in mammals. Mice defi cient in the oxalate transporter SLC26A6 demonstrate hyperoxalemia and hyperoxaluria and have CaOx stones on the basis of a defect in intestinal back-secretion of ingested oxalate. 9,10 In the kidney, SLC26A6 is responsible for chlorideoxalate exchange resulting in active chloride absorption and oxalate secretion in the proximal tubule. 11 Th us, it would be predicted that loss of chloride -oxalate exchange activity in the kidney would result in reduced oxalate excretion; however, increased oxalate excretion is observed and can be explained as follows: Th e defect in intestinal secretion leads to an increase in plasma oxalate concentration, which in turn leads to an increase in the filtered load of oxalate. Since the resulting hyperoxaluria can be accounted for by the increase in the fi ltered load of oxalate, these results are interpreted to mean that oxalate fi ltration, rather than secretion, is the primary determinant of oxalate excretion. Th us, an insect model in which urine composition is based on secretion rather than fi ltration may lead to the opposite results when compared with a mammalian model.
In clinical practice, the cornerstone of the evaluation of recurrent stone formers includes an analysis of both plasma values and urine biochemistry, obtained from a 24-h urine collection. The Drosophila model used by Chen and colleagues 5 lacks information on urinary or serum (hemolymph) biochemistry and thus leaves their fi ndings largely phenomenological.
Th e observation that the EG-fed fl ies demonstrated an increased incidence of CaOx stones and reduced lifespan does not allow any causal conclusions. In fact, a known side eff ect of EG treatment is metabolic acidosis. 12 Th us, it is conceivable that EG feeding results in a chronic metabolic acidosis, and that this is the cause of the shortened lifespan and not the higher incidence of stone formation. Th e investigators tested the eff ect of a litholytic agent in their Drosophila model and were able to demonstrate that administration of KCit decreases kidney stone formation and increases the fl y ' s lifespan as compared with that of fl ies fed EG alone.
Assuming that the luminal fl uid in Malphigian tubules contains citrate and that the amount of secreted citrate is regulated by pH, the litholytic eff ect of KCit may be secondary to correction of the hypocitraturia caused by the EG-induced metabolic acidosis. Raising the tubular fl uid citrate concentration may have contributed to the reduced rate of stone formation by binding the tubular fl uid Ca 2 + , which itself may have increased secondarily to the chronic metabolic acidosis, leaving less free Ca 2 + available to combine with oxalate. In addition, the benefi cial eff ect of a higher luminal [citrate] may be secondary to inhi bition of crystal agglomeration itself, as demonstrated in in vitro models. 13 Lastly, the litholytic eff ect of KCit may be completely unrelated to citrate but rather secondary to a higher potassium intake, which in and of itself has been shown to reduce stone formation by reducing urinary Ca 2 + excretion. 14 Without urinary and blood / hemolymph biochemistry data these questions will remain unanswered and the mechanism of CaOx formation in this model unresolved.
So is Drosophila a fruitful model of CaOx stone disease? Th e ease and power of genetics in this model cannot be overestimated with regard to its potential for helping us identify genes involved in stone pathogenesis, especially when combined with already established mouse and rat models. However, a ' great ' model is one that imitates or exactly copies the real situation, in this case the nephrolithiasis. Whether the Drosophila model is able to mimic human nephrolithiasis needs to be seen. Diff erences in tubular fl uid formation and diffi culties in following plasma values and urine biochemistry may be the ultimate limitations of this model. , and sodium oxalate (NaOx). Malphigian tubules in combination with the intestine that they drain into are considered the fruitfly renal system, as together they are responsible for regulation of salt, water, and nitrogenous waste excretion and maintenance of a homeostatic physiological state. Following the administration of lithogenic agents, stones were identified within the Malphigian tubules by polarized light microscopy. Analysis of the stones by elemental composition of the crystals identified the stones as calcium oxalate stones. Although macrophage infiltration is impor tant in renal injury that includes glome rulonephritis, 1 appropriate leukocyte recruitment and activation are also a vital step in reparative tissue responses. Persistent tubulointerstitial and glomerular macrophage infi ltration is a hallmark of chronic infl ammatory disease and a feature of many progressive renal diseases. Immunosuppression may interrupt the natural history of renal inflammatory disease but is often incompletely eff ective and is associated with treatment-related complications. Th ere is much research examining the immune mechanisms underlying chronic infl ammation and the associated inade quacy of disease resolution pathways, and it is hoped that identification of some of the cues responsible for limiting active infl ammation and initiating the resolution phase will lead to novel targeted therapies capable of aborting infl ammatory disease with an improved side-eff ect profi le. One putative ' anti-infl ammatory and resolution signal ' is the release of free extracellular adenosine, generated in response to metabolic stress and cell damage in renal ischemia or infl ammation. Adenosine A 2A receptors (A 2A Rs) are expressed across multiple cell lineages in vivo , including endothelium, epithelium, and multiple leukocyte subsets. Ligation of leukocyte A 2A R is associated with the opposition of infl ammatory activation; hence the adenosine -receptor system can be viewed as an elegant endogenous feedback system opposing persisting and injurious immune activation with promotion of the switch to a resolution phenotype.
Garcia et al. 2 (this issue) present work detailing the impact of pharmacological A 2A R agonism and antagonism on the outcome of established proteinuric antiglomerular basement membrane (anti-GBM) nephritis with drug treatment commenced 14 days aft er disease initiation. Th e data presented build on their previous work showing that A 2A R agonism from the time of disease initiation reduced disease severity. 3 Th e initiation of treatment in established disease used in the current study off ers a better analogy to the typical presentation and treatment of patients with rapidly progressive glomerulonephritis and enhances the translational importance of the fi ndings.
Garcia et al. 2 report that the administration of the A 2A R agonist CGS 21680 has a prompt and sustained impact in lessening proteinuria and prevents progressive elevation in serum creatinine. CGS 21680treated animals exhibited reduced disease severity with a remarkable reduction in glomerular macrophage infi ltration associated with reduced levels of the chemokine CCL22 as well as reduced osteopontin, thrombospondin, and transforming growth factor-mRNA levels. Notably, in kidneys treated with the agonist for 6 days, there was a reversal of established fi brosis with reduced expression of collagens III and IV and reduced interstitial myofibroblast accumulation. In contrast, A 2A R antagonism worsened disease outcome.
Th e mechanistic importance of macrophage recruitment in mediating tissue injury and subsequent fi brosis in experimental models of renal disease that includes anti-GBM nephritis is well recognized, as is its contribution to progression of human renal disease. Th us it seems likely that the marked reduction in macrophage infi ltration evident in CGS 21680-treated animals is of major significance. However, the diverse expression profi le of the A 2A R in vivo complicates definitive conclusions regarding the key cellular target of CGS 21680 in mediating the protected phenotype reported, and it thus remains possible that reduced macrophage infi ltration is an epiphenomenon refl ecting reduced tissue injury mediated by alternative, possibly multiple pathways. In order to draw defi nitive conclusions regarding the relative contributions of leukocyte and macrophage A 2A R activation to disease phenotype, studies involving bone marrow transplantation or cell lineage-restricted A 2A R activation or deletion will be necessary.
THE IMPACT OF A 2A R ACTIVATION ON OUTCOME IN EXPERIMENTAL INFLAMMATION
Th e generation of A 2A R knockout mice and the development of pharmacological
